CytomX Therapeutics, Inc.

Ownership Transactions Reported by 18 Insiders

Symbol
CTMX on Nasdaq
Industry
Pharmaceutical Preparations
Location
151 Oyster Point Blvd., Suite 400, South San Francisco, California

Insiders trading volume in the past year

CytomX Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sean A. McCarthy CEO, Director $923K -$97K -9.51% Aug 20, 2024
Marcia Belvin SVP, Chief Scientific Officer $216K -$42.8K -16.5% Aug 20, 2024
Lloyd Rowland General Counsel $161K -$28.9K -15.2% Aug 20, 2024
Jeffrey B. Landau Chief Business Officer $156K -$29.8K -16.1% Aug 20, 2024
Yu-Waye Chu Chief Medical Officer $140K Jan 18, 2024
Christopher Ogden Chief Financial Officer $133K -$11.4K -7.89% Aug 20, 2024
Amy C. Peterson EVP, Chief Development Officer $80.7K Mar 16, 2023
Carlos Campoy Chief Financial Officer $52.8K Mar 16, 2023
Alison L. Hannah Chief Medical Officer $44K Jul 19, 2022
Zhen Su Director May 15, 2024
Elaine V. Jones Director May 15, 2024
Frederick W. Gluck Director Jun 15, 2022
James R. Meyers Director May 15, 2024
John A. Scarlett Director Jun 16, 2021
Alan Ashworth Director May 15, 2024
Mani Mohindru Director May 15, 2024
Matthew P. Young Director May 15, 2024
Halley E. Gilbert Director May 15, 2024

Recent Insider Transactions by Companies or Individuals for CytomX Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.